-
RedHill Biopharma Announces Pricing of $20 Million Underwritten Offering
-
Redhill Biopharma (RDHL) PT Lowered to $20 at Roth Capital Following 3Q Release
-
RedHill Biopharma Announces Closing of Public Offering of its American Depositary Shares
-
RedHill Biopharma Reports 2017 Third Quarter Financial Results
-
RedHill Biopharma (RDHL) Prices 4.1M ADS Offering at $5.50/Sh
-
RedHill Biopharma Prices Public Offering of its American Depositary Shares
-
RedHill Biopharma Announces Exercise of Underwriters’ Option
-
RedHill Biopharma Announces Closing of Concurrent Public Offering and Registered Direct Offering of its American Depositary Shares and Warrants and Partial Exercise of the Option of Underwriters
-
RedHill Biopharma (RDHL) Prices Common Stock, Warrant Offering
-
RedHill Biopharma Prices Concurrent Public Offering and Registered Direct Offering of its American Depositary Shares and WarrantsÂ
-
RedHill Biopharma (RDHL) Plans to Offer ADSs and Warrants
-
RedHill Biopharma Announces Proposed Concurrent Public Offering and Registered Direct Offering of its American Depositary Shares and Warrants
-
RedHill Biopharma to Host Investor Conference Call Today at 18:00 EDT Following Announcement of Proposed Public Offering of its American Depository Shares
-
RedHill Biopharma (RDHL) Plans ADS Offering
-
RedHill Biopharma Announces Proposed Public Offering of its American Depository Shares
-
RedHill Biopharma Reports 2015 Fourth Quarter and Full-Year Financial Results
-
RedHill Biopharma Reports Results for the Third Quarter of 2015
-
RedHill Biopharma Reports Results for the Second Quarter of 2015
-
RedHill Biopharma Announces Closing of Public Offering of Its American Depository Shares
-
RedHill Biopharma (RDHL) Prices 2.46M Public Offering at $16.25/ADS
-
RedHill Biopharma Prices Public Offering of Its American Depository Shares
-
RedHill Biopharma (RDHL) to Offer 1.8M ADSs
-
RedHill Biopharma Announces Size of Proposed Public Offering of Its American Depository Shares
-
RedHill Biopharma (RDHL) Plans ADS Offering
-
RedHill Biopharma Announces Proposed Public Offering of Its American Depository Shares
-
Redhill Biopharma (RDHL) PT Raised to $30 at Roth Capital
-
RedHill Biopharma Reports Results for the First Quarter of 2015
-
RedHill Biopharma (RDHL) Prices 1M Offering at $12.50/ADS
-
RedHill Biopharma (RDHL) Reports Proposed Public Offering of ADS
-
Unusual 11 Mid-Day Movers 12/31: (NRX) (RDHL) (REN) Higher; (NDRM) (CJJD) (DRAM) Lower
-
Pre-Open Stock Movers 12/31: (NRX) (RDHL) (MIG) Higher; (NDRM) (GSAT) Lower (more...)
-
Roth Capital Starts Redhill Biopharma (RDHL) at Buy

